Panel Recommends Novartis' Kidney Transplant Drug Certican
This article was originally published in The Pink Sheet Daily
Executive Summary
Taking the panel's previous advice to demonstrate everolimus' efficacy with lower doses of cyclosporine is what gained the committee endorsement Dec. 7.